A RETROSPECTIVE COMPARATIVE-STUDY EVALUATING THE RESULTS OF MILD HYPERTHERMIC VERSUS CONTROLLED NORMOTHERMIC PERFUSION FOR RECURRENT MELANOMA OF THE EXTREMITIES

被引:25
作者
KLAASE, JM
KROON, BBR
EGGERMONT, AMM
VANGEEL, AN
KOOPS, HS
OLDHOFF, J
LIENARD, D
LEJEUNE, FJ
BERKEL, R
FRANKLIN, HR
HART, AAM
机构
[1] NETHERLANDS CANC INST, DEPT SURG, AMSTERDAM, NETHERLANDS
[2] DR DANIEL DEN HOED CANC CTR, DEPT SURG ONCOL, 3008 AE ROTTERDAM, NETHERLANDS
[3] UNIV GRONINGEN HOSP, DEPT SURG ONCOL, GRONINGEN, NETHERLANDS
[4] INST JULES BORDET, B-1000 BRUSSELS, BELGIUM
[5] NETHERLANDS CANC INST, DEPT BIOMETR, AMSTERDAM, NETHERLANDS
[6] NETHERLANDS CANC INST, DEPT RADIOTHERAPY, AMSTERDAM, NETHERLANDS
关键词
REGIONAL ISOLATED PERFUSION; RECURRENT MELANOMA; MILD HYPERTHERMIA; MELPHALAN;
D O I
10.1016/0959-8049(94)00372-C
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate the role of mild hyperthermia (39-40 degrees C) in isolated cytostatic perfusion for patients with recurrent melanoma of the extremities. A total of 218 patients treated with mild hyperthermic perfusion was compared to 166 patients perfused under controlled normothermic conditions (37-38 degrees C). Only patients whose lesions had been excised before or at the moment of perfusion were eligible for this study. A variety of prognostic factors was controlled for in a Cox proportional hazards analysis. The application of mild hyperthermia did not influence limb recurrence-free interval nor survival (corrected P values 0.46 and 0.18, respectively). In this retrospective comparative study, no benefit for mild hyperthermia in regional isolated perfusion could be identified.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 25 条
[1]  
BAAS PC, 1988, REG CANCER TREAT, V1, P33
[2]  
CASCINELLI N, 1991, WHO MELANOMA TRIAL 1
[3]  
CAVALIER.R, 1967, CANCER, V20, P1351, DOI 10.1002/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO
[4]  
2-#
[5]  
CAVALIERE R, 1987, PROGNOSTIC PARAMET G, V7, P163
[6]   CHEMOTHERAPY OF CANCER - REGIONAL PERFUSION UTILIZING AN EXTRACORPOREAL CIRCUIT [J].
CREECH, O ;
KREMENTZ, ET ;
RYAN, RF ;
WINBLAD, JN .
ANNALS OF SURGERY, 1958, 148 (04) :616-632
[7]  
DAHL O, 1990, INTRO PRACTICAL ASPE, P108
[8]   REGIONAL HYPERTHERMIC PERFUSION WITH MELPHALAN AFTER SURGERY FOR RECURRENT MALIGNANT-MELANOMA OF THE EXTREMITIES [J].
HAFSTROM, L ;
RUDENSTAM, CM ;
BLOMQUIST, E ;
INGVAR, C ;
JONSSON, PE ;
LAGERLOF, B ;
LINDHOLM, C ;
RINGBORG, U ;
WESTMAN, G .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (12) :2091-2094
[9]  
HAHN GM, 1982, HYPERTHERMIA CANCER
[10]   THE EFFECT OF SYSTEMIC HYPERTHERMIA ON MELPHALAN PHARMACOKINETICS IN MICE [J].
HONESS, DJ ;
DONALDSON, J ;
WORKMAN, P ;
BLEEHEN, NM .
BRITISH JOURNAL OF CANCER, 1985, 51 (01) :77-84